These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33172464)

  • 1. Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study.
    Park SJ; Ha KH; Kim DJ
    Cardiovasc Diabetol; 2020 Nov; 19(1):191. PubMed ID: 33172464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between body mass index and clinical outcomes after new-generation drug-eluting stent implantation: Korean multi-center registry data.
    Kim BG; Hong SJ; Kim BK; Ahn CM; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2018 Oct; 277():155-162. PubMed ID: 30216914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obesity paradox in patients with acute coronary syndromes over 2 decades - the ACSIS registry 2000-2018.
    Gurevitz C; Assali A; Mohsan J; Gmach SF; Beigel R; Ovdat T; Zwas DR; Kornowski R; Orvin K; Eisen A
    Int J Cardiol; 2023 Jun; 380():48-55. PubMed ID: 36940822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
    Pagidipati NJ; Zheng Y; Green JB; McGuire DK; Mentz RJ; Shah S; Aschner P; Delibasi T; Rodbard HW; Westerhout CM; Holman RR; Peterson ED;
    Am Heart J; 2020 Jan; 219():47-57. PubMed ID: 31707324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
    Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High high-sensitivity C-reactive protein/BMI ratio predicts future adverse outcomes in patients with acute coronary syndrome.
    Jia L; Yuan JQ; Zhu L; Zhang Y
    Coron Artery Dis; 2019 Sep; 30(6):448-454. PubMed ID: 31386638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity Paradox in the Intrahospital and Follow-Up Phases of the Acute Coronary Syndrome: A Meta-Analysis and Systematic Review.
    Mornar Jelavic M; Babic Z; Pintaric H
    Cardiology; 2023; 148(6):528-544. PubMed ID: 37552961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome.
    Rossello X; Ferreira JP; Caimari F; Lamiral Z; Sharma A; Mehta C; Bakris G; Cannon CP; White WB; Zannad F
    Clin Res Cardiol; 2021 Oct; 110(10):1612-1624. PubMed ID: 33929598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study.
    Kim YG; Han KD; Choi JI; Boo KY; Kim DY; Oh SK; Lee KN; Shim J; Kim JS; Kim YH
    Cardiovasc Diabetol; 2019 Oct; 18(1):128. PubMed ID: 31575379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of body mass index on long-term outcomes in patients undergoing percutaneous coronary intervention stratified by diabetes mellitus: a retrospective cohort study.
    Rao C; Zhong Q; Wu R; Li Z; Duan Y; Zhou Y; Wang C; Chen X; Wang R; He K
    BMC Cardiovasc Disord; 2024 Feb; 24(1):113. PubMed ID: 38365597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome.
    Jong CB; Li HY; Pan SL; Hsieh MY; Su FY; Chen KC; Yin WH; Chan SH; Wu YW; Wang KY; Chang KC; Hwang JJ; Wu CC
    J Am Heart Assoc; 2019 Apr; 8(7):e011215. PubMed ID: 30905254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Body Mass Index to Outcomes in Acute Coronary Syndrome.
    Ratwatte S; Hyun K; D'Souza M; Barraclough J; Chew DP; Shetty P; Patel S; Amos D; Brieger D;
    Am J Cardiol; 2021 Jan; 138():11-19. PubMed ID: 33058799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
    Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
    JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
    Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between body mass index and prognosis of patients presenting with potential acute coronary syndromes.
    Dooley J; Chang AM; A Salhi R; Hollander JE
    Acad Emerg Med; 2013 Sep; 20(9):904-10. PubMed ID: 24050796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.
    Diercks DB; Roe MT; Mulgund J; Pollack CV; Kirk JD; Gibler WB; Ohman EM; Smith SC; Boden WE; Peterson ED
    Am Heart J; 2006 Jul; 152(1):140-8. PubMed ID: 16824844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and long-term outcomes after incident stroke: a prospective population-based cohort study.
    Akyea RK; Doehner W; Iyen B; Weng SF; Qureshi N; Ntaios G
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2111-2121. PubMed ID: 34581015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term and long-term adverse cardiovascular events across the glycaemic spectrum in patients with acute coronary syndrome: the Gulf Registry of Acute Coronary Events-2.
    Alfaleh HF; Alhabib KF; Kashour T; Ullah A; Alsheikhali AA; Al Suwaidi J; Sulaiman K; Al Saif S; Almahmeed W; Asaad N; Amin H; Al-Motarreb A; Mimish L; Hersi A
    Coron Artery Dis; 2014 Jun; 25(4):330-8. PubMed ID: 24525788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the 'obesity paradox' phenomenon is still apparent.
    Patsa C; Toutouzas K; Tsiamis E; Tsioufis C; Spanos A; Karanasos A; Michelongona A; Tousoulis D; Stefanadis C
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):307-13. PubMed ID: 21917434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of Waist-Hip Ratio to Long-Term Cardiovascular Events in Patients With Coronary Artery Disease.
    Medina-Inojosa JR; Batsis JA; Supervia M; Somers VK; Thomas RJ; Jenkins S; Grimes C; Lopez-Jimenez F
    Am J Cardiol; 2018 Apr; 121(8):903-909. PubMed ID: 29482851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.